Year: 2025
Type: article
Study design: Observational Study
Abstract: BACKGROUND Women with an elevated risk for breast cancer due to a BRCA 1 or BRCA 2 pathogenic variant can choose for surveillance or Risk Reducing Mastectomy (RRM). Breast Reconstruction improves Quality of Life (QoL). However, in this High-Risk population, the effect of breast reconstruction on QoL nor the level of satisfaction afterward is widely researched. This cross-sectional study aimed to determine the long-term satisfaction level with breast reconstruction in a high-risk breast cancer population. METHOD Women who underwent breast reconstruction were invited to complete several online questionnaires including the BREAST-Q, SF-36, general questions on their health and DNA test results, and the course of diagnosis and treatment. In the analyses two groups were compared: patients with breast reconstruction after risk-reducing mastectomy (BRaRRM) and patients with breast reconstruction after breast cancer (BRaBC). RESULTS 935 participants completed all questionnaires of whom 535 underwent breast reconstruction and were included in this analysis. There was no difference between BREAST-Q ‘satisfaction with outcome' scales between the BRaRRM and BRaBC groups (60.9 vs 60.9). According to our multivariable linear regression analysis, higher age had a positive association with satisfaction with outcome, and both secondary and implant-based reconstruction were negatively associated with satisfaction with outcome (b= 0.21, b = -2.10, b = -5.83). CONCLUSION RRM combined with breast reconstruction is a good option for women with high risk of breast cancer. No difference in the BREAST-Q satisfaction with outcome scale was observed between both groups. Age, type, and timing of reconstruction should be considered when deciding on RRM.
Source: JPRAS Open
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $1,920
Funders: Amsterdam University Medical Centers, Universiteit Leiden, Rijksuniversiteit Groningen, Radboud Universiteit, Universiteit Maastricht, Erasmus Medisch Centrum, Nederlandse Organisatie voor Wetenschappelijk Onderzoek, Maastricht Universitair Medisch Centrum, KWF Kankerbestrijding, Leids Universitair Medisch Centrum, Radboud Universitair Medisch Centrum
OpenAlex ID: W4416528145
